Mindera raises over $12M to commercialize an RNA sequencing based skin test

May 13, 2021 Leave a comment 2,397 Views

Mindera Corporation today announced a $12.6M Series A-2 capital raise. The round was led by Mountain Group Partners, Rockmont Investments, and Scientific Health Development. The funding will be used to commercialize Mind.Px, a groundbreaking tool to prospectively predict patient response to expensive ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Mindera

Mindera raises over $12M to commercialize an RNA sequencing based skin test

VAX-seq – mRNA vaccine quality analysis using RNA sequencing

Single-cell RNA-sequencing integration analysis revealed immune cell heterogeneity in five human autoimmune diseases

Tasmanian tiger RNA is first to be recovered, sequenced from an extinct animal

mitoSplitter – A mitochondrial variants-based method for efficient demultiplexing of pooled single-cell RNA-seq

“CHOOSE” – CRISPR-human organoids-scRNA-seq

SAHMI – denoising sparse microbial signals from single-cell sequencing of mammalian host tissues

Aging is associated with a systemic transcriptome imbalance